18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.

18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.

To evaluate the added value of the application of the liver-specific contrast phase of Gadobenate dimeglumine (Gd-BOPTA) for detection and characterization of liver lesions in 18F-FDG PET/MRI.41 patients with histologically confirmed solid tumors and known / suspected liver metastases or not classif...

Full description

Bibliographic Details
Main Authors:	Julian Kirchner, Lino M Sawicki, Cornelius Deuschl, Johannes Grüneisen, Karsten Beiderwellen, Thomas C Lauenstein, Ken Herrmann, Michael Forsting, Philipp Heusch, Lale Umutlu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5500282?pdf=render

Similar Items

Severe Adverse Drug Reaction to Gadobenate Dimeglumine
by: Benjamin D. Singer, et al.
Published: (2009-01-01)

Comparison of Gadopentetate dimeglumine and Gadobenate dimeglumine in depiction of non-ischemic fibrosis in hypertrophic cardiomyopathy
by: Schulz-Menger Jeanette, et al.
Published: (2009-01-01)

Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.
by: Karsten Beiderwellen, et al.
Published: (2015-01-01)

Single dose gadobenate dimeglumine for imaging chronic of myocardial infarction in comparison to double dose gadopentetate dimeglumine
by: Huber Armin M, et al.
Published: (2009-01-01)

Comparison of gadoxetic acid and gadobenate dimeglumine, liver-specific contrast agents used in magnetic resonance imaging in differential diagnosis of liver masses
by: Mehmet Akcicek, et al.
Published: (2020-03-01)

Nebulized liposomal gadobenate dimeglumine contrast formulation for magnetic resonance imaging of larynx and trachea
by: Wei X, et al.
Published: (2011-12-01)

A Comparison between Gadofosveset Trisodium and Gadobenate Dimeglumine for Steady State MRA of the Thoracic Vasculature
by: G. Paul Camren, et al.
Published: (2014-01-01)

Contrast-enhanced whole heart coronary MRI with a bolus infusion of gadobenate dimeglumine at 1.5 t
by: Manning Warren J, et al.
Published: (2010-01-01)

Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium
by: Marcelo Souto Nacif, et al.
Published: (2018-01-01)

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.
by: Julian Kirchner, et al.
Published: (2017-01-01)

Non-enhanced T1-weighted liver vessel imaging at 7 Tesla.
by: Anja Fischer, et al.
Published: (2014-01-01)

1023 Correlation of chronic left ventricular infarct size assessed with 0.2 mmol/kg of gadopentetate dimeglumine (Gd-DTPA) and 0.1 mmol/kg gadobenate dimeglumine (Gd-BOPTA)
by: Lane Kimberly, et al.
Published: (2008-10-01)

Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancer.
by: Johannes Grueneisen, et al.
Published: (2014-01-01)

18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis.
by: Cornelius Deuschl, et al.
Published: (2020-01-01)

Dual-energy CT of liver metastases in patients with uveal melanoma
by: Jens Altenbernd, et al.
Published: (2016-01-01)

Diagnostic Performance of Simultaneous [<sup>18</sup>F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis: A Prospective Study
by: Jost Langhorst, et al.
Published: (2020-08-01)

Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors.
by: Cornelius Deuschl, et al.
Published: (2016-01-01)

1.5 versus 3 versus 7 Tesla in abdominal MRI: A comparative study.
by: Anja Laader, et al.
Published: (2017-01-01)

Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
by: Verena Ruhlmann, et al.
Published: (2017-12-01)

<sup>18</sup>F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?
by: Yan Li, et al.
Published: (2020-09-01)

Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectives
by: Candelario N, et al.
Published: (2016-06-01)

Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)
by: Ying Ding, et al.
Published: (2018-12-01)

Treatment response after radioembolisation in patients with hepatocellular carcinoma—An evaluation with dual energy computed-tomography
by: Jens Altenbernd, et al.
Published: (2016-01-01)

Evaluation of the Predictive Potential of 18F-FDG PET and DWI Data Sets for Relevant Prognostic Parameters of Primary Soft-Tissue Sarcomas
by: Michal Chodyla, et al.
Published: (2021-06-01)

Suspected hepatotoxicity effect of amiodarone (amiodarone and liver)
by: Unić-Stojanović Dragana 0000-0002-7066-6292 0000-0002-7066-6292, et al.
Published: (2017-01-01)

Value of using liver FDG uptake as background activity in standardizing FDG PET/CT studies
by: Wilson, Colin Michael
Published: (2019)

Evaluation of serum prolidase activity as a marker for liver fibrosis in suspected liver disease
by: Stanfliet, John Christian
Published: (2015)

Diagnostic Performance of Ultrasonography in Detecting Fatty Liver Disease in Comparison with Fibroscan in People Suspected of Fatty Liver
by: Leila Kamali, et al.
Published: (2019-01-01)

Hepatitis E virus detection in liver tissue from patients with suspected drug-induced liver injury
by: Obinna eChijioke, et al.
Published: (2015-03-01)

FDG-PET in suspected dementia with Lewy bodies: a case report
by: Astrid Melani Suantio, et al.
Published: (2019-05-01)

Evaluation of FDG-PET/CT Use in Children with Suspected Infection or Inflammation
by: Fabienne G. Ropers, et al.
Published: (2020-09-01)

Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model
by: Shu-ting Wang, et al.
Published: (2019-01-01)

A Contrast Examination of Proinflammatory Effects on Kidney Function for γ-Fe2O3 NP and Gadolinium Dimeglumine
by: Xie Q, et al.
Published: (2021-03-01)

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
by: Benedikt Michael Schaarschmidt, et al.
Published: (2015-01-01)

Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children
by: Peige Song, et al.
Published: (2017-04-01)

MR Assessment of liver and pancreas steatosis in chronic liver diseases
by: João Pedro Ferreira Silva Vieira
Published: (2020)

Quantitative imaging of the liver with 18F-FDG PET/CT in patients with hepatic steatosis
by: Keramida, Georgia
Published: (2016)

Towards fast whole-body PET/MR: Investigation of PET image quality versus reduced PET acquisition times.
by: Maike E Lindemann, et al.
Published: (2018-01-01)

IgG serum antibody responses in suspected liver cystic echinococcosis patients
by: Radonjić Ivana V., et al.
Published: (2007-01-01)

Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.
by: Juliane Goebel, et al.
Published: (2017-01-01)